Plain-English translation of NCT06893757 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study following 2,000 people in France who have just been diagnosed with tuberculosis and are starting treatment. Researchers want to understand how well the treatment works, what happens to patients over the next two years, and how different health conditions, life circumstances, and personal factors affect treatment success and recovery.
Tuberculosis is a serious infection that affects people differently depending on their age, health status, living situation, and other medical conditions. By carefully tracking patients receiving the treatment, researchers can learn what factors help or hinder recovery, and how to better support people with tuberculosis—especially those facing additional challenges like homelessness, poverty, or other serious health conditions.
You likely qualify if…
You likely don't qualify if…
You would be followed by the research team for up to 24 months after starting your tuberculosis treatment. During this time, researchers would collect information about your health, symptoms, test results, and how you're doing—including questions about your living situation, any other health conditions, and how the treatment is affecting your daily life. You would not receive any new or experimental medication; instead, the study simply observes and documents your experience with standard tuberculosis treatment.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
France